601567 三星醫療
按盤價 
23.410 -1.250 (-5.069%) | 2025/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 7,972,214 | 13.93% | 14,600,478 | 11,462,508 | 9,098,203 | 7,022,902 | |
| 減：營業總成本 | 6,798,039 | 16.23% | 12,231,893 | 9,763,005 | 8,045,107 | 6,520,178 | |
| 其中:營業成本 | 5,662,488 | 23.72% | 9,530,647 | 7,575,015 | 6,470,477 | 5,241,357 | |
| 財務費用 | (114,664) | -312.03% | 158,627 | (8,838) | (14,853) | 88,302 | |
| 資產減值損失 | (37,258) | 155.39% | (56,494) | (12,987) | (11,539) | (13,066) | |
| 公允價值變動收益 | 25,303 | -150.65% | (172,769) | 116,975 | (107,481) | 103,697 | |
| 投資收益 | 119,397 | -7.14% | 229,188 | 296,137 | 84,951 | 204,334 | |
| 其中：對聯營企業和合營企業的投資收益 | 109,974 | 6.71% | 194,975 | 230,272 | 189,892 | 134,226 | |
| 營業利潤 | 1,381,833 | 5.04% | 2,585,133 | 2,270,452 | 1,152,349 | 851,227 | |
| 利潤總額 | 1,401,226 | 3.13% | 2,672,557 | 2,262,067 | 1,152,047 | 846,813 | |
| 減：所得稅費用 | 186,312 | -8.91% | 399,319 | 341,263 | 187,042 | 139,204 | |
| 淨利潤 | 1,214,913 | 5.27% | 2,273,237 | 1,920,804 | 965,005 | 707,609 | |
| 減：非控股權益 | (14,819) | -462.50% | 13,720 | 17,102 | 16,889 | 17,567 | |
| 股東淨利潤 | 1,229,732 | 6.93% | 2,259,518 | 1,903,702 | 948,116 | 690,043 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.870 | 7.41% | 1.600 | 1.350 | 0.670 | 0.500 | |
| 每股派息 (元) * | 0.485 | -- | 0.890 | 0.650 | 0.350 | 0.320 | |
| 每股淨資產 (元) * | 8.621 | 9.52% | 8.562 | 7.794 | 6.729 | 6.333 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 22/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
